Allergy & Immunology Denial Appeal Automation: Accelerate Revenue Capture

The Specific Challenges of Allergy & Immunology Denial Appeals

Allergy & Immunology practices frequently encounter denials for high-cost treatments, including asthma biologics like Xolair and Dupixent, IVIG/SCIG, and specialized allergen immunotherapy. These denials often stem from issues such as medical necessity disputes, documentation gaps, or specific payer policy interpretations. Manual appeal processes exacerbate these issues, leading to significant administrative burden, delayed patient care, and substantial revenue leakage due to unaddressed or poorly managed appeals.

Manual Appeal Workflows: Bottlenecks in Allergy & Immunology

• **Denial Routing Decision:** Staff manually determines if a case is appealable, requires peer-to-peer review, or resubmission.
• **Manual Documentation Gathering:** Pulling additional clinical documentation from the EMR, such as updated lab results (e.g., IgE levels, FEV1), treatment plans, or specialist notes, that were not in the original submission.
• **Manual Appeal Letter Drafting:** Coordinators or clinicians painstakingly draft appeal letters, often needing to cite specific clinical guidelines or peer-reviewed literature for complex immunology cases.
• **Appeal-Pathway Determination & Submission:** Navigating varied payer appeal levels and submitting via disparate channels (portals, fax, mail), each with unique requirements and timely-filing windows.
• **Manual Tracking:** Labor-intensive tracking of appeal status, outcomes, and critical deadlines, leading to lost-to-follow-up cases.

Klivira's Automated Approach to Allergy & Immunology Denial Appeals

Klivira's denial appeal automation platform is engineered to address the specific complexities of allergy & immunology. By leveraging advanced automation, we transform the reactive, manual appeal process into a proactive, efficient workflow. Our system integrates with existing EMRs and payer portals to streamline the entire appeal lifecycle, from denial classification to submission and outcome tracking, ensuring critical treatments for asthma, autoimmune conditions, and severe allergies are not unnecessarily delayed.

Core Automation Capabilities for Allergy & Immunology Practices

• **Denial Classification:** Klivira's denial router uses normalized CARC/RARC taxonomy to classify denials, automatically routing them to the appropriate appeal pathway based on payer-specific policies.
• **FHIR-Based Documentation Re-Discovery:** Automatically pulls comprehensive clinical evidence from the EMR, including new notes, updated lab results, imaging, and relevant peer-reviewed literature for off-label or complex cases, ensuring robust appeal packets.
• **Payer-Template Appeal Letter Assembly:** Composes precise appeal letters from per-payer templates that directly address specific denial reasons. For clinical-necessity appeals common in biologics and IVIG, Klivira drafts a clinician-reviewable letter with literature citations, ready for approval or editing.
• **Automated Submission:** Submits appeals via the payer's accepted channel—appeal portal, fax fallback, or PAS-conformant resubmission—adhering to X12 278 and Da Vinci PAS standards where applicable.
• **Status Tracking & Timely-Filing Enforcement:** Automated tracking with real-time status updates, timely-filing window enforcement, and escalation rules to prevent lost appeals.
• **Outcome Capture & Feedback:** Appeal outcomes are captured and written back to the EMR as DocumentReference and Communication resources, providing valuable pattern feedback to improve upstream PA submission success for high-volume PA categories like asthma biologics and IVIG.

Seamless EMR Integration and Payer Connectivity

Klivira's platform ensures seamless integration with your existing EMR systems via SMART on FHIR, enabling automated extraction of critical clinical data like lab results (e.g., specific IgE, IgG subclass levels), physician notes, and treatment histories essential for allergy & immunology appeals. This robust connectivity extends to payer portals and other channels, facilitating efficient submission of appeal packets and real-time status updates, minimizing manual intervention and data re-entry.

Improving Revenue Cycles and Patient Access in Allergy & Immunology

By implementing allergy & immunology denial appeal automation, practices can significantly reduce the administrative burden and rework costs associated with manual processes, as indicated by industry benchmarks like the CAQH Index. Faster, more accurate appeals lead to quicker approvals for high-cost therapies, improving both the practice's financial health and patient access to essential care. This strategic automation allows your team to focus on patient care rather than administrative overhead.